Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Study - GMMG-HD 7 - Lenalidomide 10 / Isatuximab 10, Multiple Myeloma, Maintenance, IIB, Cycle 2-3

Protocol-ID: 46 V1.1 (Mini), STUDY-GMMG-HD7 - LENA10/ISAT10, MM, maint., IIB, C2-3
Study protocol, available to authorized participants only.

Indication(s)

  • Multiple Myeloma; ICD-10 C90.-, C90.0-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 19.06.2020